Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative vaginal chlorhexidine-cetrimide versus povidone-iodine before cesarean section in Lagos
PACTR202308689414142Recruiting
- Sponsor
- Ohiomoba Gladys
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine gluconate + cetrimide and povidone-iodine in surgical site infection (SSI), endometritis and Endomyometritis (2 arms), sponsored by Ohiomoba Gladys. Primary endpoint: Incidence of post-caesarean composite infectious morbidity. Started Aug 2023; status: recruiting.
02
Drugs
chlorhexidine gluconate + cetrimidepovidone-iodine
03
Conditions
surgical site infection (SSI)endometritisEndomyometritis
Beyond the preview
Go deeper on PACTR202308689414142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308689414142.